Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
D&D Pharmatech
Biotech
Neuraly points to younger patients as Parkinson's bet fails
A Parkinson’s disease treatment from Neuraly did not improve motor experiences of daily living or movement in a midstage trial.
Annalee Armstrong
Mar 27, 2023 10:37am
D&D Pharma nabs $51M before Korean IPO for Alzheimer's
Oct 19, 2021 7:00am
D&D bags $137M to fund Alzheimer's, Parkinson's trials
Aug 14, 2019 8:05am